Trial Profile
A phase I/II trial of AIR-001 for the treatment of Pseudomonas aeruginosa infection in cystic fibrosis patients
Status:
Recruiting
Phase of Trial:
Phase I/II
Latest Information Update: 09 Mar 2017
Price :
$35
*
At a glance
- Drugs Sodium nitrite (Primary)
- Indications Pseudomonal infections
- Focus Adverse reactions; Proof of concept
- 09 Mar 2017 New trial record